Zacks Investment Research on MSN
SNPS Stock Plunges 25% in 3 Months: Should You Buy, Sell or Hold?
Synopsys SNPS stock has lost 25.3% in the past three months, underperforming the Zacks Computer - Software industry’s return ...
A team of researchers has developed the first high-resolution genetic map and a versatile SNP chip for Panax ginseng, a tetraploid medicinal plant with complex genomic architecture. These tools are ...
Synopsys expands in AI cluster interconnects with new Ultra Accelerator Link and Ultra Ethernet IP to power next-generation ...
Synopsys' EDA dominance, deep client integration, and IP portfolio ensure resilience. Read more about SNPS stock and why it ...
Case study for application of SNP chip across inbreeding population which bred and maintained by pureline selection. Five accessions (A–E) were inspected and two individuals from each accession were ...
Synopsys' AI-driven EDA tools and recent acquisitions like ANSYS are fueling adoption, but competition and lowered earnings ...
Synopsys is the leading vendor of electronic design automation software tools used for integrated circuit design, and the #2 ...
We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Synopsys, Inc. (NASDAQ:SNPS) stands against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results